(Q45365068)

13 December 2017

title

Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population (English)

1 reference

13 December 2017

0 references

1 reference

1 reference

Wanyu Li

1

1 reference

13 December 2017

Yanfang Jiang

2

1 reference

13 December 2017

Qinglong Jin

3

1 reference

13 December 2017

Xiaodong Shi

4

1 reference

13 December 2017

Jinglan Jin

5

1 reference

13 December 2017

Yanhang Gao

6

1 reference

13 December 2017

Yu Pan

7

1 reference

13 December 2017

Hong Zhang

8

1 reference

13 December 2017

Jing Jiang

9

1 reference

13 December 2017

Junqi Niu

10

1 reference

13 December 2017

publication date

30 March 2011

1 reference

13 December 2017

1 reference

13 December 2017

volume

31

1 reference

13 December 2017

issue

8

1 reference

13 December 2017

page(s)

1118-1126

1 reference

Epidemiology of hepatitis B virus infection in the Asia-Pacific region

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02507.X

Antiviral therapy of the Asian patient with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02507.X

Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02507.X

Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen-negative patients receiving lamivudine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02507.X

Genomics in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02507.X

Molecular viral oncology of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02507.X

Cytokine gene polymorphisms in patients infected with hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02507.X

Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02507.X

Association of estrogen receptor alpha polymorphisms with susceptibility to chronic hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02507.X

Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02507.X

A comparative review of HLA associations with hepatitis B and C viral infections across global populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02507.X

Hepatitis B virus enhances interleukin-27 expression both in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02507.X

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02507.X

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02507.X

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02507.X

Interferon-alfa, interferon-lambda and hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02507.X

Association of interferon-gamma gene haplotype in the Chinese population with hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02507.X

Lambda interferon inhibits hepatitis B and C virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02507.X

Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02507.X

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02507.X

Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02507.X

Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02507.X

LONG-TERM FOLLOW-UP IN A RANDOMISED CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B INFECTION

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02507.X

10.1111/J.1478-3231.2011.02507.X

21 January 2018

Identifiers

DOI

1 reference

13 December 2017

1 reference